Amplicon details |
||
Amplicon: |
195 bp | |
1 gctcctacaa atgccatcat tgcgataaag gaaaggccat cgttgaagat 51 gcctctgccg acagtggtcc caaagatgga cccccaccca cgaggagcat 101 cgtggaaaaa gaagacgttc caaccacgtc ttcaaagcaa gtggattgat 151 gtgatatctc cactgacgta agggatgacg cacaatccca ctatc |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
NRN_AR229556 | nrnl1 | Sequence 29 from patent US 6448476.... | 2107 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_CS576679 | nrnl1 | Sequence 40 from Patent WO2007027776. | 6641 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_GM060301 | nrnl1 | Sequence 141 from Patent WO20080633... | 18662 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_CQ897009 | nrnl1 | Sequence 17 from Patent WO2004092211. | 4789 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_AR229557 | nrnl1 | Sequence 31 from patent US 6448476.... | 2436 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_GM828044 | nrnl1 | Sequence 15 from Patent WO2008114282. | 1729 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_BD251966 | nrnl1 | Artificial matrix attachment region... | 10629 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_GM716142 | nrnl1 | Sequence 170 from Patent WO20081005... | 21767 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_CS576667 | nrnl1 | Sequence 28 from Patent WO2007027776. | 4257 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_FW498196 | nrnl1 | Mammalian-type glycosylation in pla... | 1229 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_BD394364 | nrnl1 | A construct capable of release in c... | 1294 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_FW561188 | nrnl1 | Methods for blocking plant pathogen... | 1251 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_CS646701 | nrnl1 | Sequence 43 from Patent WO200705907... | 9522 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_AR229554 | nrnl1 | Sequence 25 from patent US 6448476.... | 2122 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_CS576673 | nrnl1 | Sequence 34 from Patent WO2007027776. | 2148 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_GM828036 | nrnl1 | Sequence 7 from Patent WO2008114282. | 1759 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_CS646846 | nrnl1 | Sequence 101 from Patent WO20070618... | 13268 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_HI578395 | nrnl1 | Sequence 11 from Patent WO2010114989. | 9142 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_CQ792354 | nrnl1 | Sequence 99 from Patent WO200402064... | 5544 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
NRN_HV549895 | nrnl1 | JP 2011527180-A/111: Influenza Viru... | 747 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.